News

In a study of the immune systems of mice, scientists at Johns Hopkins Medicine say they have found a new role for a protein, ...
When your social media account starts spewing out nonsensical or threatening status updates, it's safe to assume that it has ...
Cells don’t just follow a rigid script when responding to stress – they’re far more adaptable than we thought. A new study ...
Chemotherapy drugs can kill cancer cells by halting DNA replication, but a glucose-depleted environment can help cancer cells overcome this effect and resist death. Sahana is a science journalist and ...
Cancer cells are cells gone wrong — in other words, they no longer respond to many of the signals that control cellular growth and death. Cancer cells originate within tissues and, as they grow ...
Back in 2014, a woman with advanced cancer pushed Adrienne Boire’s scientific life in a whole new direction. The cancer, which had begun in the breast, had found its way into the patient’s spinal ...
By disrupting this enzyme, researchers believe they can trigger cancer cell death, potentially changing the course of ...
Once reintroduced back into the body, the T cells replicate, creating a surge of cancer-fighting immune cells. The results of Vitanza’s early-stage clinical trial were published in Nature ...
Ultimately, it will help develop personalised therapy plans, highlighting specific changes that could be targeted in conditions such as cancer. Every cell in the human body communicates with its ...
Researchers have discovered that cancer cells suppress 'poison exons' -- genetic elements that act as an off switch for protein production -- in a key gene called TRA2 , promoting tumor growth.
AstraZeneca to buy EsoBiotec for up to $1 billion Deal aims to enhance cancer cell therapy capabilities AstraZeneca secures global rights to Alteogen's ALT-B4 enzyme AstraZeneca shares up almost ...